Abbott reaches agreements to resolve portion of litigation over infant formula
20/08/2026 21:26
Abbott reaches agreements to resolve portion of litigation over infant formula Aug 20 (Reuters) - Abbott ABT.N said on Thursday it has reached agreements with three law firms to resolve its case and claims involving about 2,000 individuals relating to the company's specialty formulas for preterm infants.
(Reporting by Sneha S K; Editing by Shinjini Ganguli)
Recent news on Abbott Laboratories
See all newsBrief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement